Performance Value of Research of Occult Gastrointestinal Bleeding by Immunoassay in the Diagnostic Process of Iron Deficiency Anemia in Patients Over 75 Years (STRATAGANEMIE)

February 10, 2021 updated by: Assistance Publique - Hôpitaux de Paris

This study aims to characterize the diagnostic performance of immunological testing of occult gastrointestinal bleeding in stool in the population aged over 75 years with iron deficiency anemia.

As secondary objectives, the study aims to:

  • determine a threshold of positivity optimizing the immunoassay performance for the study population, in accordance with the probabilities of error (false positives, false negatives) and weights (defined by expert consensus) allocated to these errors.
  • Assess the benefit of a double measure of bleeding (two stools) by immunoassay compared to a single measure.

Study Overview

Status

Completed

Detailed Description

Immunological testing will be performed systematically for each patient.

Research of blood in fecal sample will be based on 2 methods: one based on a qualitative immunochromatographic method (such as HemSign4 technique, Servibio, France; or all other techniques used at AP-HP) and another quantitative immunoturbidimetric method (OC-Sensor, Eiken, Japan). They will be performed systematically with two fresh fecal samples for each patient, before coloscopy examination.

Treating physicians will not be provided with the testing result. The diagnosis of reference will be established by experts based on the result of explorations (colonoscopy, coloscanner) and the patient's progression, blinded to the result of immunoassay.

The intrinsic characteristics of the immunoassay (sensitivity, specificity...) will be determined with reference to this reference diagnosis, using a positivity threshold defined using expert consensus on the weights to be allocated to potential errors.

2 modeling scenarios (without vs with immunological testing) using decision trees based on prevalence and diagnostic performance observed and stochastic simulations.

Study Type

Observational

Enrollment (Anticipated)

200

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Hauts-de-Seine
      • Boulogne-Billancourt, Hauts-de-Seine, France, 92100
        • Service Hépato-Gastroentérologie, Hôpital Ambroise Paré

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

75 years and older (OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

200 people at least 75 years old.

Description

Inclusion Criteria:

  • Physical status score 3 or 4, aged 75 and older patient, (patients under guardianship may be included).
  • Iron deficiency anemia (Hb≤120 g/l for a woman or Hb≤130 g/l for a man), and nonregenerative anemia with reticulocytes <120 000/mm3.
  • Patient who has indication for colonoscopy and / or colonography examination, whatever the results of gastroscopy if performed.
  • Have a health insurance.
  • Informed consent signed.

Exclusion Criteria:

  • Hematemesis or melena
  • Life expectancy inferior to 12 months
  • Patient has difficulty in follow-up of study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sensitivity of immunological test with OC-SENSOR supplies
Time Frame: At baseline

The immunological test with OC-SENSOR supplies is a quantitative determination of hemoglobin, the method of detection of lower gastrointestinal hemorrhagic lesions of older population with iron deficiency anemia.

Sensitivity of the immunological test will be calculated statistically.

At baseline
Specificity of immunological test with OC-SENSOR supplies
Time Frame: At baseline

The immunological test with OC-SENSOR supplies is a quantitative determination of hemoglobin, the method of detection of lower gastrointestinal hemorrhagic lesions of older population with iron deficiency anemia.

Specificity of the immunological test will be calculated statistically.

At baseline
Likelihood ratios of immunological test with OC-SENSOR supplies
Time Frame: At baseline

The immunological test with OC-SENSOR supplies is a quantitative determination of hemoglobin, the method of detection of lower gastrointestinal hemorrhagic lesions of older population with iron deficiency anemia.

Likelihood rations of the immunological test will be calculated statistically.

At baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Diagnostic Performance
Time Frame: At baseline
Diagnostic Performance of predictive equation incorporating all individual data will be calculated statistically.
At baseline
Comparing scenarios using decision trees
Time Frame: At baseline
Compare using modeling (decision trees) the causal efficiency (number of origins of bleeding detected / number of coloscopy-colonoscopy performed) of two scenarios: without (base case) and with the immunoassay to research occult bleeding in feaces (with one or two fecal samples).
At baseline
Performance of the test when used with an optimized positivity threshold
Time Frame: At baseline
Sensitivity, specificity and likelihood ratios of the immunological testing will be calculated statistically, when an optimized positivity threshold for the population under study is used, as a function of weights (defined by experts consensus) allocated to errors (false negative and false positive cases).
At baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Dominique Lamarque, MD, PhD, Service Hépato-Gastroentérologie, Hôpital Ambroise Paré

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

July 1, 2016

Primary Completion (ACTUAL)

September 5, 2019

Study Completion (ACTUAL)

September 5, 2019

Study Registration Dates

First Submitted

March 8, 2016

First Submitted That Met QC Criteria

March 29, 2016

First Posted (ESTIMATE)

April 4, 2016

Study Record Updates

Last Update Posted (ACTUAL)

February 11, 2021

Last Update Submitted That Met QC Criteria

February 10, 2021

Last Verified

February 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Occult Gastrointestinal Bleeding

3
Subscribe